| HCC | Hepatocellular Carcinoma |
| ICC | Intrahepatic Cholangiocarcinoma |
| cHCC-CCA | Combined Hepatocellular-Cholangiocarcinoma |
| TACE | Transarterial Chemoembolization |
| TKI | Tyrosine Kinase Inhibitor |
| ECM | Extracellular Matrix |
| GSCA | Gene Set Cancer Analysis |
| CTRP | The Cancer Therapeutics Response Portal |
| WB | Western Blotting |
| CCK-8 | Cell Counting Kit-8 |
| PVDF | Polyvinylidene Fluoride |
| FBS | Fetal Bovine Serum |
| SPF | Specific Pathogen-Free |
| IACUC | Institutional Animal Care and Use Committee |
| OS | Overall Survival |
| PFS | Progression-Free Survival |
| IC50 | Half-Maximal Inhibitory Concentration |
| CI | Combination Index |
| EMT | Epithelial-Mesenchymal Transition |
| FAK | Focal Adhesion Kinase |
| KEGG | Kyoto Encyclopedia of Genes and Genomes |
| siRNA | Small Interfering RNA |
| shRNA | Short Hairpin RNA |
| KO | Knockout |